Intrastromal Fresh Human Corneal Lenticule Implantation Using Smile Surgery for Treatment of Irregular Corneal Astigmatism After Penetrating Keratoplasty (New Approach)

Sponsor
Eye Hospital Pristina Kosovo (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04987060
Collaborator
(none)
24
1
1
84
0.3

Study Details

Study Description

Brief Summary

The aim of the study is to present the effect of implanting intrastromal fresh corneal lenticule by SMILE surgery as a new method-approach to correct the corneal shape on purpose to reduce irregular astigmatism and increasing visual acuity after penetrating keratoplasty.

Condition or Disease Intervention/Treatment Phase
  • Device: Intrastromal Fresh Human Lenticule Implantation
N/A

Detailed Description

Irregular astigmatism occurs when the curvature of the eye is pronounced in any direction, not just the center. The curve could be steeper towards the bottom than on top, or it could be any configuration in which the eye's surface area is uneven.

Irregular astigmatism usually can result from corneal degenerations(keratoconus,pellucid marginal degeneration,keratoglobus), corneal surgery or trauma.

Irregular astigmatism is still the main cause of decreased visual acuity after penetrating keratoplasty.

Our study present new therapeutic method and new technology to manage irregular astigmatism after PK. Knowing that the incidence of high and irregular astigmatism after PK is still a frequent complication and source of frustration for patients and corneal surgeons our study present an adequate surgical technique implanting intrastromal human corneal lenticule using SMILE for treatment of corneal irregular astigmatism after PK trying satisfy patients visual expectations.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Irregular astigmatism groupIrregular astigmatism group
Masking:
None (Open Label)
Masking Description:
irregullar astigmatism group
Primary Purpose:
Treatment
Official Title:
Intrastromal Fresh Human Corneal Lenticule Implantation Using Smile Surgery for Treatment of Irregular Corneal Astigmatism After Penetrating Keratoplasty (New Approach)
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Mar 1, 2021
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Intrastromal Fresh Human Lenticule Implantation

The aim of this study is to investigate the effect of intrastromal fresh corneal lenticule implantation using Smile module surgery after PK with primary objective to increase visual acuity by reducing irregular astigmatism according to high K values. The stromal pocket diameter was 8 mm, 2mm super incision, 140-µm cap thickness and fresh lenticular implantation is performed.

Device: Intrastromal Fresh Human Lenticule Implantation
The stromal pocket diameter was set 8.0 mm and cap thickness was set to 140 μm from corneal surface and a 2mm superior incision. Hinge position flap was set at 90°, angle 50° and width 4 mm, side cut angle 90°. The pocket was dissected using a blunt spatula washed with normal saline. The lenticule was held with lenticule forceps and gently inserted into the pocket through the 2 mm superior incision. Incision position changed according to the position of the highest K values.

Outcome Measures

Primary Outcome Measures

  1. Increase of visual acuity [12 months]

    Using intrastromal fresh corneal lenticule resulted in the increase of the visual acuity.

Secondary Outcome Measures

  1. Decrease of irregular astigmatism [12 months]

    In order to stabilize irregular astigmatism and reduce K-values, the intrastromal fresh corneal lenticule was implanted.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with irregular astigmatism

  • low visual acuity

Exclusion Criteria:
  • history of glaucoma

  • retinal detachment

  • history of ocular inflamation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Hospital Pristina Pristina Kosovo 10000

Sponsors and Collaborators

  • Eye Hospital Pristina Kosovo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Faruk Semiz, Head of Ophthalmology Department, Eye Hospital Pristina Kosovo
ClinicalTrials.gov Identifier:
NCT04987060
Other Study ID Numbers:
  • EyeHPristina2
First Posted:
Aug 3, 2021
Last Update Posted:
Aug 3, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2021